Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
7.90
+0.96 (13.83%)
At close: May 28, 2025, 4:00 PM
7.89
-0.01 (-0.13%)
After-hours: May 28, 2025, 4:38 PM EDT
Ocular Therapeutix Employees
Ocular Therapeutix had 274 employees as of December 31, 2024. The number of employees increased by 7 or 2.62% compared to the previous year.
Employees
274
Change (1Y)
7
Growth (1Y)
2.62%
Revenue / Employee
$217,690
Profits / Employee
-$703,325
Market Cap
1.26B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
OCUL News
- 14 days ago - Ocular Therapeutix™ to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Ocular Therapeutix™ to Participate in Two Investor Conferences in April - GlobeNewsWire
- 2 months ago - Ocular Therapeutix Axpaxli Advances In Phase 3 For Wet AMD, Analyst Forecasts Huge Upside - Benzinga
- 2 months ago - Ocular Therapeutix: Axpaxli's Dual Trial Strategy And Blockbuster Potential - Seeking Alpha
- 3 months ago - Ocular Therapeutix, Inc. (OCUL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2024 Results on March 3, 2025 - GlobeNewsWire
- 4 months ago - Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting - GlobeNewsWire